A chromosomal translocation is a rearrangement in which a segment of one chromosome breaks off and reattaches to a different chromosome, or two chromosomes swap pieces with each other. This happens when the DNA in a cell sustains double-strand breaks and the repair machinery reconnects the wrong ends. Translocations are among the most common structural chromosome changes in people, found in roughly 1 in 250 prenatal samples in one large study, and they sit at the crossroads of cancer biology, reproductive medicine, and even human evolution.
How a Translocation Forms
The fundamental trigger is a double-strand break, the most dangerous kind of DNA damage a cell can experience. When the sugar-phosphate backbone on both strands of the double helix snaps at the same spot, the chromosome is physically severed. A single break on one chromosome is bad enough, but when two breaks happen on two different chromosomes at roughly the same time, the stage is set for a translocation. Mouse embryonic stem cell experiments showed that just two simultaneous breaks on separate chromosomes are enough to produce frequent reciprocal translocations.1Nature. Frequent chromosomal translocations induced by DNA double-strand breaks
The breaks themselves can come from many sources: ionizing radiation, certain chemicals, reactive oxygen species generated during normal metabolism, or stalled DNA replication forks. What makes the situation dangerous isn’t the break alone but what happens next. The cell activates repair pathways, and if two free chromosome ends from different chromosomes are floating nearby, the repair enzymes can accidentally stitch them together. The result is a hybrid chromosome carrying sequences from two different chromosomes that were never meant to be joined.2PubMed Central. Dynamics of double strand breaks and chromosomal translocations
The Repair Pathways That Go Wrong
Cells have two main strategies for fixing double-strand breaks. One, called homologous recombination, uses an undamaged copy of the same chromosome as a template and is usually quite accurate. The other, non-homologous end-joining (NHEJ), is faster but sloppier: it grabs nearby free DNA ends and ligates them together without checking whether they belong to the same chromosome. Many translocations arise through “classical” or “alternative” forms of NHEJ.3Nature Reviews Cancer. End-joining, translocations and cancer
The alternative NHEJ pathway is particularly error-prone. It uses tiny patches of matching sequence at the broken ends to guide ligation, but those patches can exist on completely unrelated chromosomes. Genetic rearrangements consistent with alternative NHEJ have been found in translocations tied to both spontaneous cancers and cancers that develop after chemotherapy.4PLOS Genetics. Alternative-NHEJ Is a Mechanistically Distinct Pathway of Mammalian Chromosome Break Repair So the very system meant to protect your genome can, under the wrong circumstances, rearrange it.
Why Certain Chromosomes Pair Up More Often
If translocations were purely random, every pair of chromosomes would be equally likely to swap pieces. That is not what researchers see. Some chromosome pairs are involved in translocations far more than chance would predict, and a big reason is physical proximity inside the nucleus. Chromosomes are not scattered at random in the cell: each one occupies a preferred territory, and some territories sit next to each other. When two chromosomes that happen to be neighbors both sustain breaks at the same time, the free ends are close enough for the repair machinery to grab them and join them. Work mapping the three-dimensional organization of the mouse genome showed that translocation frequency between two chromosomes tracks directly with how close they normally sit in the nucleus.5Cell. Spatial Organization of the Mouse Genome and Its Role in Recurrent Chromosomal Translocations
This spatial logic helps explain why certain cancer-associated translocations recur so predictably. It is not just that specific genes are vulnerable to breakage; it is also that those genes happen to live on chromosomes that are routinely parked side by side.6PubMed Central. Spatial genome organization in the formation of chromosomal translocations
Reciprocal Versus Robertsonian Translocations
The two broad categories you will see in genetics reports are reciprocal translocations and Robertsonian translocations. In a reciprocal translocation, two non-homologous chromosomes each break at one point, and the segments swap. If no genetic material is gained or lost, the translocation is “balanced” and the person is usually healthy, though their children may not be. In one prenatal study of 3,800 patients in North Macedonia, reciprocal translocations were found at a rate of about 0.21%, while balanced translocations overall accounted for 0.29% and unbalanced ones for 0.13%.7Europe PMC. The incidence and type of chromosomal translocations from prenatal diagnosis of 3800 patients in the republic of macedonia
Robertsonian translocations are a special case involving the acrocentric chromosomes, the ones whose centromere sits near one end (chromosomes 13, 14, 15, 21, and 22 in humans). In these, the long arms of two acrocentric chromosomes fuse together and the short arms are lost. A person who carries a Robertsonian translocation effectively has 45 chromosomes instead of 46, yet because the lost short arms contain mostly repetitive ribosomal DNA that exists in many copies elsewhere, carriers are typically unaffected. Recent work identified a common breakpoint in a macrosatellite DNA sequence called SST1, found on chromosomes 13, 14, and 21, where an inverted segment on chromosome 14 enables a crossover that fuses the long arms of two chromosomes during meiosis.8Nature. The formation and propagation of human Robertsonian chromosomes This crossover mechanism explains why certain Robertsonian translocations, particularly those involving chromosomes 13 and 14 or 14 and 21, come up again and again.9PubMed Central. A working model for the formation of Robertsonian chromosomes
Cancer and Gene Fusions
The most medically consequential translocations are those that create oncogenic gene fusions. When a break occurs inside or near two different genes on two different chromosomes, the translocation can weld them together into a single hybrid gene that makes an abnormal protein. The classic example is the Philadelphia chromosome, produced by a translocation between chromosomes 9 and 22. The resulting BCR-ABL fusion gene produces a protein that acts as a permanently “on” enzyme, driving white blood cells to proliferate uncontrollably. The Philadelphia chromosome is present in virtually all patients with chronic myeloid leukemia.10Cytokine & Growth Factor Reviews. BCR-ABL: The molecular mastermind behind chronic myeloid leukemia11PubMed. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome
Translocations can also cause cancer by a different trick called enhancer hijacking. Instead of fusing two protein-coding sequences, the rearrangement places a normal gene next to powerful regulatory elements that crank up its expression. In Burkitt lymphoma, the MYC gene is moved next to one of the immunoglobulin loci on a different chromosome. The immunoglobulin enhancers, which are normally very active in B cells, force MYC to pump out far more protein than the cell can safely handle, pushing the cell toward malignancy.12Nature Reviews Disease Primers. Burkitt lymphoma
Chemicals and Drugs That Promote Translocations
Not all translocations arise from bad luck during routine DNA repair. Some are directly triggered by chemicals that interfere with an enzyme called topoisomerase II, which normally untangles DNA during replication and gene expression by creating temporary, controlled breaks and resealing them. Certain chemotherapy drugs, including etoposide and doxorubicin, trap topoisomerase II after it has cut the DNA, preventing resealing and turning a controlled nick into a permanent double-strand break. Regimens that include these drugs are linked to therapy-related leukemias featuring translocations at specific chromosome bands.13PubMed Central. Topoisomerase II and leukemia
Researchers have shown that the translocation breakpoints in leukemias that develop after mitoxantrone exposure cluster tightly in an eight-base-pair region, exactly where topoisomerase II is known to cut when exposed to the drug.14PubMed. DNA topoisomerase II in therapy-related acute promyelocytic leukemia Even natural compounds in certain foods can act on topoisomerase II in a similar way. Infant leukemias with the same translocation patterns as therapy-related leukemias have been associated with gestational diets high in naturally occurring topoisomerase II-active compounds, such as flavonoids found in fruits and vegetables.15PubMed Central. Secondary leukemia associated with the anti-cancer agent, etoposide, a topoisomerase II inhibitor That does not mean eating fruit causes cancer; the association points to a mechanism by which certain substances can, in rare circumstances, generate the specific DNA breaks that lead to translocations.
What Balanced Carriers Face in Reproduction
A person carrying a balanced translocation usually has no symptoms because all the genetic material is present, just rearranged. The trouble shows up when they try to have children. During meiosis, the cell has to sort the rearranged chromosomes into eggs or sperm, and the shuffling doesn’t always produce balanced sets. In one large study characterizing over 1,800 embryos from reciprocal translocation carriers, only about 41% of embryos received the balanced “alternate” segregation pattern that leads to a healthy outcome. The rest had various unbalanced arrangements: roughly 28% from so-called adjacent-1 segregation, about 11% from adjacent-2, and the remainder from other abnormal patterns.16Human Reproduction. Analysis of segregation patterns of quadrivalent structures and the effect on genome stability during meiosis in reciprocal translocation carriers
Unbalanced embryos typically have too much genetic material from one chromosome and too little from another. Many do not implant at all or miscarry early, which is why recurrent pregnancy loss is one of the most common reasons a balanced translocation carrier comes to medical attention. Some unbalanced outcomes are compatible with life but cause developmental disabilities or birth defects. The degree of risk depends on which chromosomes are involved and how asymmetric the rearrangement is. Carriers with more severely asymmetric rearrangements tend to produce fewer balanced embryos and more abnormal ones.17Reproductive BioMedicine Online. Quadrivalent asymmetry in reciprocal translocation carriers predicts meiotic segregation patterns in cleavage stage embryos
Preimplantation genetic testing (PGT) has become a practical option for translocation carriers undergoing IVF. By screening embryos before transfer, clinicians can select those with a balanced chromosome complement. Even among unbalanced embryos, adjacent-1 segregation is the most common pattern, though the distribution shifts with maternal age.18PubMed Central. Analysis of clinical outcomes and meiotic segregation modes following preimplantation genetic testing for structural rearrangements
How Translocations Are Detected
The oldest method is karyotyping: growing cells in culture, arresting them in the middle of division, staining the chromosomes, and lining them up to look for anything out of place. Karyotyping can catch large rearrangements but misses smaller ones. Fluorescence in situ hybridization (FISH) improved resolution by using fluorescent probes that bind to specific chromosome regions, lighting up a translocation when two probes that should be on separate chromosomes end up side by side. FISH works on preserved tissue samples, which makes it especially valuable in cancer pathology.19PubMed Central. Fluorescence in situ hybridization in surgical pathology: principles and applications
More recently, optical genome mapping has emerged as a way to detect translocations at gene-level resolution, surpassing what karyotyping and even FISH can achieve.20PubMed Central. Evaluation of optical genome mapping for detecting chromosomal translocation in clinical cytogenetics Whole-genome sequencing is also increasingly used, especially in cancer diagnostics where identifying the exact fusion gene matters for choosing the right drug. The technology has changed fast enough that some translocations once considered cryptic, invisible to standard karyotyping, are now routinely found.
Targeted Therapies Built Around Fusion Genes
Knowing the specific translocation driving a cancer has opened the door to remarkably precise treatments. The poster child is imatinib, a tyrosine kinase inhibitor designed to block the BCR-ABL fusion protein in chronic myeloid leukemia. It transformed CML from a near-certain death sentence into a manageable chronic condition. Since then, dozens of kinase inhibitors have been developed to target various fusion proteins. An analysis of 28 FDA-approved targeted therapies found that drugs aimed at fusion gene targets produced a median response rate of about 68%, compared with 50% for drugs targeting non-fusion mutations. In solid tumors specifically, the difference was even more pronounced: 74% versus 51%.21PubMed Central. Targeting fusions for improved outcomes in oncology treatment
More recent approvals have pushed the approach even further. Larotrectinib and entrectinib, approved in 2018 and 2019, target NTRK fusions across any solid tumor type, regardless of where in the body the cancer originated. This was a conceptual shift: rather than treating a breast cancer or a lung cancer, oncologists began treating the fusion itself.22Signal Transduction and Targeted Therapy. Oncogenic gene fusions in cancer: from biology to therapy These drugs work because the translocation creates a distinctive molecular target that normal cells do not carry, making the treatment relatively selective.23PubMed Central. Clinical characterization and therapeutic targeting of fusion genes in oncology
Chromothripsis and Catastrophic Rearrangements
Most translocations involve a single swap between two chromosomes. But in some cases, a chromosome is shattered into dozens or even hundreds of fragments in a single catastrophic event and then reassembled in a scrambled order. This phenomenon, called chromothripsis, can produce a bewildering tangle of translocations, deletions, and duplications all at once. It is associated with both cancer and congenital conditions.24PubMed Central. Chromosomal Rearrangements and Chromothripsis: The Alternative End Generation Model Chromothripsis was only recognized in 2011, and its discovery upended the assumption that cancer genomes always accumulate mutations gradually. In some tumors, a single disastrous cell division can rewrite much of the genome in one step.
CRISPR and Unintended Translocations
The gene-editing tool CRISPR-Cas9 works by creating a targeted double-strand break, which is exactly the kind of lesion that starts a translocation. Researchers have confirmed that CRISPR can induce translocations between the intended target chromosome and other chromosomes, especially when the enzyme cuts at an off-target site simultaneously.25Nature Communications. The hidden risks of CRISPR/Cas: structural variations and genome integrity Recent work developing specialized reporter systems found a markedly increased frequency of translocations after CRISPR activation, with the risk going up when the cut site sits near certain repetitive DNA sequences called inverted repeats.26PubMed Central. Assessment and Mitigation of CRISPR-Cas9-Induced Nontargeted Translocations This is an active area of concern for therapeutic gene editing, because a translocation introduced during treatment could, in theory, create the same kind of oncogenic rearrangement that drives cancer. Newer editing strategies, such as base editing and prime editing, aim to avoid double-strand breaks altogether, partly to sidestep this risk.
Hidden Translocations and Recurrence Risk in Families
When a child is born with a developmental disorder caused by a chromosomal deletion or duplication, genetic testing often labels the change “de novo,” meaning it apparently arose for the first time in that child rather than being inherited. Parents are typically reassured that their recurrence risk is very low. But in some cases, what looks like a new mutation in the child is actually the unbalanced product of a balanced insertional translocation hidden in one of the parents. A study of nearly 14,300 patients with developmental abnormalities found that insertional translocations underlie about 2% of apparently de novo copy number changes, making them at least six times more common than previously assumed.27European Journal of Human Genetics. Parental insertional balanced translocations are an important cause of apparently de novo CNVs in patients with developmental anomalies Because a parent carrying a balanced insertion has a 50% chance of passing the unbalanced version to each future child, missing this diagnosis drastically underestimates recurrence risk. Confirming whether a parent carries a balanced rearrangement has real consequences for family planning.
Translocations in Human Evolution
Not all translocations are harmful. Some have been fixed in entire species over evolutionary time. The most famous example involves human chromosome 2, which is the product of an ancient head-to-head fusion of two chromosomes that remain separate in chimpanzees, gorillas, and other great apes. Sequence analysis of the 2q13-2q14.1 region reveals remnants of telomeric and subtelomeric DNA embedded in the middle of the chromosome, exactly where the tips of the two ancestral chromosomes would have met.28PubMed Central. Genomic structure and evolution of the ancestral chromosome fusion site in 2q13-2q14.1 and paralogous regions on other human chromosomes This fusion is the reason humans have 46 chromosomes while our closest primate relatives have 48. It likely occurred in a single individual and spread through the population over hundreds of thousands of years, eventually becoming universal in Homo sapiens. In evolutionary terms, a translocation that does not disrupt critical genes and is compatible with normal fertility can become permanently fixed.
Evolutionary translocations can also reshape gene regulation. When a rearrangement moves a gene next to new regulatory DNA, it can change where and when that gene is expressed. Comparative studies between mice and humans show that translocation and inversion breakpoints often land at the boundaries of topologically associating domains, the structural loops that organize DNA in three dimensions. When those boundaries are disrupted, regulatory elements from one domain can start driving genes in another, creating species-specific gene expression patterns that may have contributed to evolutionary divergence.29PubMed Central. Topologically associating domains are disrupted by evolutionary genome rearrangements forming species-specific enhancer connections in mice and humans